This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Social Bookmarking   What's this?

Ian Kerridge, BMed, MPhil; Michael Lowe, BMed; Michael Seldon, MBBS, BSc Med, FRACP, FRCPA; Arno Enno, MBBS, FRACP, FRCPA; Sandra Deveridge, MBBS, BSc Med

Arch Intern Med. 1997;157(15):1753-1757.

Abstract
We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.

Arch Intern Med. 1997;157:1753-1757

Author Affiliations
From the Health Law and Ethics Program, University of Newcastle (Drs Kerridge and Lowe), and the Hematology Unit, Mater Hospital (Drs Kerridge, Seldon, Enno, and Deveridge), Newcastle, Australia.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Medical Ethics in the Treatment of Jehovah's Witnesses
Osamu Muramoto
Arch Intern Med. 1998;158(10):1155-1156.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Faith, Identity, and Leukemia: When Blood Products are Not an Option
Knuti et al.
The Oncologist 2002;7:371-380.
ABSTRACT | FULL TEXT  

Medical Ethics in the Treatment of Jehovah's Witnesses
Muramoto
Arch Intern Med 1998;158:1155-1156.
FULL TEXT